Walgreens expands telehealth services to app users in additional states

Article

The MDLive telehealth services available through Walgreens’ mobile application are now available to users in 25 states and promises better functionality and integration.

The MDLive telehealth services available through Walgreens’ mobile application are now available to users in 25 states and promises better functionality and integration.

Editor’s Choice: mHealth tools: A bond between patients and pharmacists

Additionally, Walgreens has launched its Walgreens Connect app, which allows Walgreens Balance Rewards members who own specific blood glucose testing and blood pressure monitoring systems to earn points for taking daily measurements.

The mobile app provides around-the-clock access to MDLIVE’s network of U.S. board-certified doctors.

“Walgreens provides convenient and connected services for our customers, and we are thrilled to be advancing our digital experience to provide patients with more choices when it comes to accessing care,” said Adam Pellegrini, Walgreens divisional vice president of digital health.

“We have seen that telehealth solutions play an important role in helping to improve patient outcomes, and we will continue to work to evolve our offerings to ensure our patients can choose what’s most convenient for them whether that’s live doctor consultations, digitally chatting with a pharmacist, or visiting a Healthcare Clinic,” he added.

Until now, the MDLive telehealth services were only available to Walgreens app users in California, Michigan, Colorado, Illinois, and Washington.

The services are now also available to users in Alabama, Arizona, California, Colorado, Connecticut, Florida, Indiana, Illinois, Iowa, Maryland, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New York, North Carolina, Ohio, Oregon, South Carolina, Tennessee, Virginia, Washington, and Wisconsin.

For more on Walgreens, click here.

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.